Back to GILD
WealthBridge Investment Counsel Inc. → GILD
WealthBridge Investment Counsel Inc. GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
4
Latest value
$9.5M
Q3 2026
Peak value
$9.5M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $7.9M |
| Q1 2026 | $8.9M |
| Q2 2026 | $8M |
| Q3 2026 | $9.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $9.5M | 63.6K | — | — |
| Q2 2026 | $8M | 63.6K | — | — |
| Q1 2026 | $8.9M | 63.8K | — | — |
| Q4 2025 | $7.9M | 64.3K | — | — |
Other funds holding GILD
$13.3B
$12.5B
$12.5B
$11.9B
$8.3B
$7.7B
$7.7B
$7.4B
Other WealthBridge Investment Counsel Inc. positions
VGES
$24.4MVanguard FTSE Europe Index
VGES
$23.9MVanguard FTSE Europe Index
VGES
$22.7MVanguard FTSE Europe Index
VGES
$22.3MVanguard FTSE Europe Index
VGES
$20.9MVanguard FTSE Emerging Markets Index
VGES
$20.7MVanguard FTSE Emerging Markets Index
GS-PD
$20.4MGoldman Sachs
VGES
$19MVanguard FTSE Emerging Markets Index